Page last updated: 2024-08-24

telmisartan and Heart Failure

telmisartan has been researched along with Heart Failure in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (4.55)	18.2507
2000's	16 (36.36)	29.6817
2010's	20 (45.45)	24.3611
2020's	6 (13.64)	2.80

Authors

Authors	Studies
Jeong, HE; Kim, JS; Ko, H; Lim, MJ; Shin, JY; Yoo, YG	1
Cao, TT; Chen, HH; Guo, W; Lu, R; Shan, XL; Tian, J; Wang, SN; Xu, M; Zhang, C; Zhao, P; Zheng, JL	1
Awwad, ZM; El-Ganainy, SO; El-Khatib, AS; ElMallah, AI; Khattab, MM	1
Finger, S; Garlapati, V; Karbach, SH; Knopp, T; Knorr, M; Kossmann, S; Lagrange, J; Molitor, M; Münzel, T; Nguyen, TS; Rudi, WS; Ruf, W; Schüler, R; Wenzel, P; Wild, J	1
Cai, Y; Chen, M; Li, H; Li, Z; Ma, S; Ou, C; Wen, Z; Xu, G; Yang, Z; Zhan, J; Zhang, J	1
Aiglova, R; Cernicek, V; Danek, J; Gloger, V; Lazarova, M; Pavlu, L; Precek, J; Schee, A; Skala, T; Taborsky, M; Vicha, M	1
Cai, Y; Chang, D; Ju, S; Lu, CQ; Min, SD; Wang, YC; Xu, TT; Zhang, SJ; Zhao, Z	1
Böhm, M; Lonn, E; Mahfoud, F; Mancia, G; Mann, JFE; Redon, J; Schmieder, R; Schumacher, H; Sliwa, K; Teo, KK; Weber, M; Williams, B; Yusuf, S	1
Böhm, M; Lonn, EM; Mahfoud, F; Mancia, G; Mann, JFE; Marx, N; Redon, J; Schmieder, RE; Schumacher, H; Sliwa, K; Teo, KK; Weber, MA; Williams, B; Yusuf, S	1
Antoniou, T; Camacho, X; Gomes, T; Juurlink, DN; Mamdani, MM; Yao, Z	1
Hirooka, Y; Kishi, T; Sunagawa, K	1
Clase, C; Dagenais, GR; de Zeeuw, D; Gao, P; Heerspink, HJ; Lonn, E; Mann, JF; Sleight, P; Teo, KT; Yusuf, S	1
Böhm, M; Foulquier, S; Schmieder, R; Schumacher, H; Sleight, P; Teo, K; Unger, T; Yusuf, S	1
Bialuk, I; Bonda, TA; Kamiński, KA; Kożuch, M; Lipiec, P; Litvinovich, S; Musiał, WJ; Szymczyk, E; Taranta, A; Winnicka, MM	1
Abe, H; Adachi, H; Hattori, S; Irino, H; Kitada, H; Miyatake, K; Morisawa, D; Noda, Y; Sasaki, T; Yasuoka, Y	1
Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cotton, D; Cunha, L; Dahlöf, B; De Keyser, J; Diener, HC; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lawton, WA; Lu, C; Machnig, T; Martin, RH; Ounpuu, S; Pais, P; Palesch, Y; Roberts, R; Sacco, RL; Skvortsova, V; Teal, P; Toni, D; VanderMaelen, C; Voigt, T; Weber, M; Yoon, BW; Yusuf, S	1
Anderwald-Stadler, M; Bergmann, A; Clodi, M; Hülsmann, M; Luger, A; Morgenthaler, NG; Mörtl, D; Pacher, R; Pacini, G; Resl, M; Riedl, M; Stelzeneder, D; Struck, J; Tura, A	1
Elisaf, MS; Liberopoulos, EN; Rizos, CV	1
Barrios, V; Echarri, R; Escobar, C	1
Aizawa, Y; Gurusamy, N; Kodama, M; Ma, M; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K	1
Gao, J; Liu, L; Ma, L; Meng, X; Wang, L; Wang, P; Wang, W; Wu, H; Wu, W; Zhang, W	1
Calabrò, R; Cice, G; D'Andrea, A; D'Isa, S; Di Benedetto, A; Gatti, E; Marcelli, D	1
Fang, JC; Sipahi, I	1
Clase, CM; Gao, P; Grosshennig, A; Mann, JF; McQueen, M; Teo, KK; Tobe, SW; Wang, X; Yusuf, S	1
Ge, JB; Guan, AL; Li, JM; Liang, YY; Ma, Z; Mi, SL; Wu, J; Yao, ZF; Zou, YZ	1
Ruilope, LM	1
Liu, LS; Tan, HQ; Teo, KK; Wang, GG; Yu, LT; Zhu, J	1
Gurusamy, N; Kodama, M; Lakshmanan, AP; Ma, M; Sukumaran, V; Suzuki, K; Veeraveedu, PT; Watanabe, K; Yamaguchi, K	1
Cao, K; Chen, XM; Huang, HJ; Huang, J; Lu, XZ; Qin, XY; Yang, XH; Yong, YH; Zheng, HJ; Zong, WN	1
Avezum, A; Dans, A; Ferreira, R; Gafni, A; Gao, P; Lamy, A; Teo, K; Tong, W; Wang, X; Young, J; Yusuf, S	1
Terra, SG	1
Matos, L	1
Bodizs, G; Cebanu, M; Grosz, CS; Pop, D; Rusu, R; Zdrenghea, D	1
Chrysant, GS; Chrysant, SG; Desai, A	1
Devereux, RB; Krauser, DG	1
Anderson, C; Gerstein, HC; Held, C; Hilbrich, L; Sleight, P; Teo, K; Yusuf, S; Zhao, F	1
Behlouli, H; Hudson, M; Humphries, K; Pilote, L; Sheppard, R; Tu, JV	1
Mitsuyama, S	1
Gremmler, B; Kisters, K; Kunert, M; Schleiting, H; Ulbricht, LJ	1
Kirk, JK	1
Arnold, JM; Azevedo, ER; Baird, MG; Butt, RW; Humen, DP; Moe, GW; Parker, AB; Parker, JD; Parker, JO; Smith, SJ	1
Dunselman, PH	1
Goa, KL; Jarvis, B; Sharpe, M	1

Reviews

8 review(s) available for telmisartan and Heart Failure

Article	Year
Are the pleiotropic effects of telmisartan clinically relevant? Current pharmaceutical design, 2009, Volume: 15, Issue:24 Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Body Fat Distribution; Cholesterol, LDL; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glucose; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Kidney; PPAR gamma; Randomized Controlled Trials as Topic; Telmisartan	2009
Telmisartan for the management of patients at high cardiovascular risk. Current medical research and opinion, 2011, Volume: 27, Issue:8 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cost of Illness; Heart Failure; Humans; Myocardial Infarction; PubMed; Ramipril; Telmisartan; Time Factors	2011
[New possibilities in clinical use of angiotensin II receptor inhibitors]. Orvosi hetilap, 2003, Dec-07, Volume: 144, Issue:49 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Ramipril; Renin-Angiotensin System; Survival Analysis; Telmisartan; Treatment Outcome	2003
Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan. Journal of human hypertension, 2005, Volume: 19, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Heart Failure; Humans; Hypertension; Renal Insufficiency; Stroke; Telmisartan; Treatment Outcome	2005
Ventricular hypertrophy and hypertension: prognostic elements and implications for management. Herz, 2006, Volume: 31, Issue:4 Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan	2006
[ARB: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects]. Nihon rinsho. Japanese journal of clinical medicine, 2007, May-28, Volume: 65 Suppl 5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Contraindications; Heart Failure; Humans; Hypertension; Imidazoles; Losartan; Telmisartan; Tetrazoles; Valine; Valsartan	2007
Angiotensin-II receptor antagonists: their place in therapy. American family physician, 1999, Volume: 59, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Heart Failure; Humans; Hypertension; Irbesartan; Losartan; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan	1999
Telmisartan: a review of its use in hypertension. Drugs, 2001, Volume: 61, Issue:10 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Drug Interactions; Heart Failure; Humans; Hypertension; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome	2001

Trials

14 trial(s) available for telmisartan and Heart Failure

Article	Year
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. European heart journal, 2018, 09-01, Volume: 39, Issue:33 Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Ramipril; Risk Assessment; Single-Blind Method; Stroke; Telmisartan; Treatment Outcome	2018
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. European heart journal, 2019, 07-01, Volume: 40, Issue:25 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus; Diastole; Drug Therapy, Combination; Heart Failure; Hospitalization; Humans; Hypertension; Myocardial Infarction; Peripheral Arterial Disease; Ramipril; Retrospective Studies; Risk Factors; Stroke; Systole; Telmisartan	2019
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial. European journal of preventive cardiology, 2014, Volume: 21, Issue:3 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hyperkalemia; Hypertension; Hypokalemia; Kidney; Kidney Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Nonlinear Dynamics; Odds Ratio; Potassium; Proportional Hazards Models; Ramipril; Renal Dialysis; Renin-Angiotensin System; Risk Assessment; Risk Factors; Stroke; Telmisartan; Time Factors; Treatment Outcome	2014
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis. Journal of hypertension, 2014, Volume: 32, Issue:6 Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cardiovascular System; Coronary Artery Disease; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Stroke; Telmisartan; Treatment Outcome	2014
Comparison of the effects of telmisartan and olmesartan on home blood pressure, glucose, and lipid profiles in patients with hypertension, chronic heart failure, and metabolic syndrome. Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:5 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Chronic Disease; Female; Glycated Hemoglobin; Heart Failure; Heart Rate; Humans; Hypertension; Imidazoles; Lipid Metabolism; Lipids; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Natriuretic Peptide, Brain; Telmisartan; Tetrazoles	2008
Telmisartan to prevent recurrent stroke and cardiovascular events. The New England journal of medicine, 2008, Sep-18, Volume: 359, Issue:12 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Female; Follow-Up Studies; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Potassium; Secondary Prevention; Stroke; Telmisartan; Treatment Failure	2008
Interactions of glucose metabolism and chronic heart failure. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2009, Volume: 117, Issue:3 Topics: Benzimidazoles; Benzoates; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; Chronic Disease; Heart Failure; Humans; Lipid Metabolism; Middle Aged; Obesity; Telmisartan; Tetrazoles	2009
Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial. Journal of the American College of Cardiology, 2010, Nov-16, Volume: 56, Issue:21 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Italy; Length of Stay; Male; Middle Aged; Morbidity; Prospective Studies; Renal Dialysis; Survival Rate; Telmisartan; Time Factors; Treatment Outcome	2010
Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies. Circulation, 2011, Mar-15, Volume: 123, Issue:10 Topics: Aged; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Ramipril; Stroke; Telmisartan; Treatment Outcome	2011
Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data. Chinese medical journal, 2011, Volume: 124, Issue:12 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; China; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Ramipril; Telmisartan	2011
Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation, 2007, Mar-20, Volume: 115, Issue:11 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Complications; Drug Therapy, Combination; Fasting; Female; Heart Failure; Hospitalization; Humans; Hyperglycemia; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Ramipril; Risk Factors; Telmisartan	2007
Effects of different AT1-receptor antagonists in the therapy of severe heart failure pretreated with ACE inhibitors. Acta cardiologica, 2007, Volume: 62, Issue:4 Topics: Acrylates; Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biomarkers; Biphenyl Compounds; Blood Pressure; Cardiac Output; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Telmisartan; Tetrazoles; Thiophenes; Treatment Outcome; Vascular Resistance	2007
ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada. American heart journal, 1999, Volume: 138, Issue:5 Pt 1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Benzimidazoles; Benzoates; Canada; Catheterization, Peripheral; Coronary Care Units; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Renin; Safety; Telmisartan; Treatment Outcome	1999
Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investi International journal of cardiology, 2001, Volume: 77, Issue:2-3 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Double-Blind Method; Enalapril; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Telmisartan	2001

Other Studies

22 other study(ies) available for telmisartan and Heart Failure

Article	Year
Risk of myocardial infarction, heart failure, and cerebrovascular disease with the use of valsartan, losartan, irbesartan, and telmisartan in patients. Medicine, 2023, Nov-17, Volume: 102, Issue:46 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Cerebrovascular Disorders; Heart Failure; Humans; Irbesartan; Losartan; Myocardial Infarction; Retrospective Studies; Telmisartan; Tetrazoles; Valsartan	2023
Stachydrine hydrochloride alleviates pressure overload-induced heart failure and calcium mishandling on mice. Journal of ethnopharmacology, 2020, Feb-10, Volume: 248 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Arterial Pressure; Calcium Signaling; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiovascular Agents; Cells, Cultured; Disease Models, Animal; Heart Failure; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Proline; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel; Sarcomeres; Sarcoplasmic Reticulum; Telmisartan; Ventricular Function, Left	2020
Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats. Toxicology, 2019, 12-01, Volume: 428 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cyclic AMP-Dependent Protein Kinases; Drug Therapy, Combination; Echocardiography; Heart Failure; Male; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Pregabalin; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Telmisartan	2019
Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1. Cardiovascular research, 2021, 01-01, Volume: 117, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Disease Models, Animal; Endothelial Cells; Heart Failure; Leukocyte Rolling; Macrophages; Male; Mice, Inbred C57BL; Monocytes; Muramidase; Myeloid Cells; Myocardial Infarction; NADPH Oxidase 2; Oxidative Stress; Receptor, Angiotensin, Type 1; Signal Transduction; Telmisartan; Vasculitis	2021
Dual-ligand supramolecular nanofibers inspired by the renin-angiotensin system for the targeting and synergistic therapy of myocardial infarction. Theranostics, 2021, Volume: 11, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cells, Cultured; Drug Delivery Systems; Heart Failure; Inflammation Mediators; Ligands; Male; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Multifunctional Nanoparticles; Myocardial Infarction; Myocytes, Cardiac; Nanofibers; Precision Medicine; Rats; Reactive Oxygen Species; Renin-Angiotensin System; Telmisartan	2021
Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2022, Volume: 166, Issue:3 Topics: Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Antihypertensive Agents; Czech Republic; Heart Failure; Humans; Losartan; Neprilysin; Perindopril; Ramipril; Retrospective Studies; Telmisartan; Valsartan	2022
Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction. Experimental biology and medicine (Maywood, N.J.), 2021, Volume: 246, Issue:23 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cardio-Renal Syndrome; Diastole; Disease Models, Animal; Echocardiography; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Stroke Volume; Telmisartan; Ventricular Function, Left; Ventricular Remodeling	2021
Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2013, Sep-03, Volume: 185, Issue:12 Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Irbesartan; Losartan; Male; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Stroke; Telmisartan; Tetrazoles; Treatment Outcome	2013
Telmisartan reduces mortality and left ventricular hypertrophy with sympathoinhibition in rats with hypertension and heart failure. American journal of hypertension, 2014, Volume: 27, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Medulla Oblongata; Norepinephrine; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Telmisartan; Tetrazoles; Ventricular Function, Left	2014
Transcriptional and post-transcriptional regulation of CCN genes in failing heart. Pharmacological reports : PR, 2015, Volume: 67, Issue:2 Topics: Animals; Atrial Natriuretic Factor; Benzimidazoles; Benzoates; Connective Tissue Growth Factor; Cysteine-Rich Protein 61; Gene Expression Regulation; Heart; Heart Failure; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Telmisartan; Transcription, Genetic	2015
New data on ONTARGET: more confusion? Journal of clinical hypertension (Greenwich, Conn.), 2010, Volume: 12, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Multicenter Studies as Topic; Ramipril; Randomized Controlled Trials as Topic; Telmisartan	2010
Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy. Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:7 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autoimmune Diseases; Benzimidazoles; Benzoates; Cardiomyopathy, Dilated; Chronic Disease; Cytokines; Fibrosis; Heart Failure; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocarditis; Myocardium; Rats; Rats, Inbred Lew; Telmisartan; Ventricular Remodeling	2010
Left ventricular hypertrophy induced by abdominal aortic banding and its prevention by angiotensin receptor blocker telmisartan--a proteomic analysis. Journal of physiology and biochemistry, 2010, Volume: 66, Issue:4 Topics: Angiotensin Receptor Antagonists; Animals; Aorta; Aorta, Abdominal; Benzimidazoles; Benzoates; Blood Pressure; Echocardiography; Electrophoresis, Gel, Two-Dimensional; Heart Failure; Hypertrophy, Left Ventricular; Male; Proteomics; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Telmisartan	2010
Treating heart failure on dialysis. Finally getting some evidence. Journal of the American College of Cardiology, 2010, Nov-16, Volume: 56, Issue:21 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Failure; Humans; Italy; Length of Stay; Morbidity; Renal Dialysis; Telmisartan; Treatment Outcome	2010
The therapeutic potential of G-CSF in pressure overload induced ventricular reconstruction and heart failure in mice. Molecular biology reports, 2012, Volume: 39, Issue:1 Topics: Animals; Benzimidazoles; Benzoates; Blotting, Western; Carotid Arteries; Constriction; DNA Primers; Echocardiography; Granulocyte Colony-Stimulating Factor; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Microtubules; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Vascular Endothelial Growth Factor A	2012
Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2/angiotensin 1-7/mas receptor axis. International journal of biological sciences, 2011, Volume: 7, Issue:8 Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Benzimidazoles; Benzoates; Biomarkers; Cytokines; Disease Models, Animal; Endoplasmic Reticulum; Heart Failure; Male; Mitogen-Activated Protein Kinases; Myocarditis; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Protective Agents; Protein Subunits; Rats; Signal Transduction; Superoxides; Telmisartan	2011
Regulation of angiotensin-(1-7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure. Acta pharmacologica Sinica, 2011, Volume: 32, Issue:11 Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Antibiotics, Antineoplastic; Benzimidazoles; Benzoates; Doxorubicin; Gene Expression Regulation; Heart; Heart Failure; Losartan; Male; Myocardium; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Telmisartan	2011
The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study. Journal of medical economics, 2011, Volume: 14, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cost of Illness; Diabetes Complications; Health Services; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Telmisartan	2011
Cardiology patient page. Angiotensin receptor blockers. Circulation, 2003, Jun-24, Volume: 107, Issue:24 Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Diuretics; Dizziness; Drug Combinations; Drug Interactions; Heart Failure; Humans; Hypertension; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Olmesartan Medoxomil; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan	2003
[Therapy of hypertension. Lasting organ protection moves into the foreground]. MMW Fortschritte der Medizin, 2003, Nov-20, Volume: 145, Issue:47 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Myocardial Infarction; Ramipril; Receptor, Angiotensin, Type 1; Stroke; Telmisartan; Treatment Outcome	2003
The acute effect of ACEI and ARB's upon endothelin in heart failure patients. Romanian journal of internal medicine = Revue roumaine de medecine interne, 2003, Volume: 41, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Endothelin-1; Endothelins; Heart Failure; Humans; Indoles; Middle Aged; Telmisartan	2003
Angiotensin II receptor blockers for the treatment of heart failure: a class effect? Pharmacotherapy, 2007, Volume: 27, Issue:4 Topics: Age Factors; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; British Columbia; Drug Prescriptions; Female; Heart Failure; Hospital Information Systems; Humans; Irbesartan; Losartan; Male; Ontario; Proportional Hazards Models; Quebec; Retrospective Studies; Survival Analysis; Survival Rate; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan	2007